FDA lifts clinical hold on Filana’s simufilam for TSC-related epilepsy
TradingView News reports the FDA lifted the clinical hold on Filana’s simufilam for TSC-related epilepsy.
TradingView News reports the FDA lifted the clinical hold on Filana’s simufilam for TSC-related epilepsy.